Page last updated: 2024-11-07

oxandrolone and Prostatic Neoplasms, Castration-Resistant

oxandrolone has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Oxandrolone: A synthetic hormone with anabolic and androgenic properties.

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Xiang, W1
Wang, S1

Reviews

1 review available for oxandrolone and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Therapeutic Strategies to Target the Androgen Receptor.
    Journal of medicinal chemistry, 2022, 07-14, Volume: 65, Issue:13

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Humans; Male; Prostatic Neoplasms, Castration-R

2022